Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics

N Engl J Med. 2021 Jul 1;385(1):74-75. doi: 10.1056/NEJMe2108276. Epub 2021 Jun 16.

Author

Roberta L DeBiasi¹

Affiliation

¹ From the Division of Pediatric Infectious Diseases, Children's National Hospital and Research Institute, and George Washington University School of Medicine, Washington, DC.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biological Products*
Glucocorticoids* / therapeutic use
Humans
Immunoglobulins, Intravenous
Immunologic Factors / therapeutic use
Immunotherapy

Substances

Biological Products
Glucocorticoids
Immunoglobulins, Intravenous
Immunologic Factors